Joost J. Oppenheim
NIH/NCI, MD, USA
Title: Oncolytic Reagents may also Enhance Anti-Tumor Immunity by Inducing MyD88-dependent Maturation of Dendritic Cells
Guido Kroemer
Gustave Roussy Comprehensive Cancer Center, INSERM, France
Title: Overcoming a frequent inborn immune defect in breast cancer therapy
Lauren V. Wood
Chief Medical Officer, PDS Biotechnology, NJ
Title: Versamune (R-D0TAP): a Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens
Wayne Godfrey
Vice President of Clinical Development at IGM Bioscience
Title: Novel Approach to Engineering Antibody Based Immunotherapy
Scott K. Durum
NCI/CCR, NIH
MD, USA
Title: TBA
Eduardo Davila
University of Colorado CU Comprehensive Cancer Center, CO
Title: Novel Gene Platforms to Maintain the Persistence and Antitumor Activity of TIL-, CAR-, and DC-Based Therapies
William Hearl
Ph.D. CEO, Immunomic Therapeutics, MD
Title: UNITE Platform, A Direct Antigen Presentation Approach in Oncology
Brian Francica
Tempest Therapeutics, CA
Title: Dual Antagonism of Prostaglandin Receptors EP2 and EP4 by TPST-1495 Suppresses Tumor Growth and Stimulates Antitumor Immunity
Jing H. Wang
University of Colorado Anschutz Medical Campus, CO
Title: MHC Class-I Independent Activation of Virtual- Memory CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells
Pooja Jain
Drexel University College of Medicine, Philadelphia, PA
Title: The MAPK/ERK-regulated MEF-2 isoforms as potential new target(s) for HTLV-1 induced Adult T-cell leukemia/lymphoma (ATLL)
Jason D. Marshall
Leidos Biomedical Research, Inc., NCI Campus at Frederick, MD
Title: Performance Optimization of a Novel HPV VLP Vaccine in Mice with Novel Adjuvants
Joseph Markowitz
Moffit Cancer Center, FL
Title: Duality of NO in Melanoma
Jean Gariepy
Sunnybrook Research Institute, Toronto, Canada
Title: Development of high-valency protein-based agonists as immunomodulators
Yan Leyfmann
Penn State College of Medicine, PA
Title: Finetune Your CARs: Building the Next Generation of Anti-Cancer Therapies
Jessica E. Thaxton
Medical University of South Carolina, SC
Title: Metabolic Requirements for T Cell Protein Translation in Tumors
Session on
Immune Modulation and Autoimmunity
Stephen D. Miller
Northwestern University Medical School, IL, USA
Title: Translation of a Nanoparticle-Based Delivery System for the Induction of Immune Tolerance
David Wagner
University of Colorado at Denver, CO, USA
Title: Exploring the role of CD40 in Autoimmune Inflammation: Impact on Disease
Pamela A. Guerrerio
NCI/CCR, NIH
MD, USA
Title: Tgfbr1-Mediated Defects in Squamous Epithelium Drive Local Allergic Inflammation
Session on
Immune Defense: Cellular and Molecular Response Regulation
Warren J. Leonard
NHLBI, NIH
MD, USA
Title: TBA
Patricia Gearhart
NHLBI, NIH
MD, USA
Title: B Cells in Aging
Jacques Robert
University of Rochester Medical Center, NY
Title: Roles of Non-polymorphic MHC and innate T cells in antimycobacterial immune response and tolerance.
Symposium on
Exosomes and Other Extracellular Vesicles
Philip W. Askenase
Yale University School of Medicine, CT, USA
Title: Suppressor T-cell Exosome miRNA-150 Induces APC To Release Ag/MHCpos Secondary Suppressive Exosomes, Binding TCR at the Immune Synapse to Inhibit DTH Effector T-cells
Raghu Kalluri
The University of Texas MD Anderson Cancer Center, TX, USA
Title: TBD
Kendall D. Hirschi
Baylor College of Medicine, TX, USA
Title: Impact of a Plant-Based Dietary miRNA on the Gut Microbiome